Free Ketamine Therapy? Laid Off Tech Workers Can Request Month Of 'Freedom' Program

Comments
Loading...

A considerable number of employees have been fired from their jobs at big tech firms.

Meta Platforms Inc. META, Twitter and Amazon.com Inc. AMZN have each cut staff in the past months. Field Trip Health & Wellness has since stepped up and is now offering these workers a month of its psychedelic-assisted therapy program “Freedom” at no cost.

A hybrid composed of ketamine-assisted therapy (KAP) and additional wellness practices, the new treatment program was built on an evidence-based, in-clinic protocol to aid in a flexible healing journey through conditions such as anxiety, depression and diminished self-worth.

See Also: Exclusive - New Latin American JV To Provide More Psychedelic Medical Treatments For Mental Health Conditions

Starting Nov. 30, “Freedom” is available in California and Washington with individual consultations occurring on a first-come-first-serve basis during December. 

Considering KAP is not for everyone, those eligible will receive Field Trip’s services for one month, including one ketamine-assisted therapy session -at home orally or in-clinic injectable dose- and one individual integration session with a clinician.

A Bit Of Ketamine’s History

The FDA initially approved ketamine for use as a general anesthetic in 1970, yet in 2000 researchers found that lower doses of ketamine could treat depression symptoms in a shorter time span.

Currently, ketamine prescriptions for psychiatric conditions are legal though not FDA-approved for that use -AKA “off-label” use. The exception is nasal spray esketamine, which was approved by the FDA in 2019 for Treatment-Resistant Depression (TRD) or other symptoms that have found no relief in existing therapeutics.

Although ketamine has usually been studied for treating depression cases, Field Trip’s CEO Ronan Levy believes that KAP can be “powerfully transformative for people dealing with some of the more common challenges of everyday life,” as the substance can increase production of brain neurotransmitter glutamate, which helps establish new brain pathways.

Photo courtesy by True Touch Lifestyle and Gorodenkoff on Shutterstock and Doc James on Wikimedia Commons.

AMZN Logo
AMZNAmazon.com Inc
$173.32-0.58%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
51.82
Growth
94.14
Quality
71.41
Value
49.68
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs

Posted In:

Cannabis is evolving—don’t get left behind!

Curious about what’s next for the industry and how to stay ahead in today’s competitive market?

Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.

Secure your spot now before prices go up—this is where the biggest deals and connections happen!

Get your tickets today!